4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Chronic Myeloid Leukaemia: new trials by email Literature Review of Chronic Myeloid Leukaemia trials Research Report on Chronic Myeloid Leukaemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia Nilotinib, Pegylated interferon alpha-2b, Imatinib - Chronic Myeloid Leukaemia | Phase 2 | Completed | Australasian Leukaemia and Lymphoma Group | 60 | 2014-04-11 | 2024-08-06 |
| De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia Imatinib, nilotinib, dasatinib - Chronic Myeloid Leukaemia | Phase 2 | Completed | University of Liverpool | 174 | 2013-12-01 | 2025-03-14 |
| Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers Reduced intensity haplodentical stem cell transplant, Myeloablative haploidentical stem cell transplant - Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma | Phase 2 | Completed | University College, London | 77 | 2013-03-01 | 2024-05-03 |
| WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study WT1 TCR-transduced T cells - Acute Myeloid Leukaemia, Chronic Myeloid Leukaemia | Phase 1 / Phase 2 | Completed | Cell Medica Ltd | 7 | 2012-04-01 | 2018-10-02 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (4) · Leukemia, Myeloid, Acute (2) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Bone Marrow Diseases (4) · Chronic Disease (4) · Disease Attributes (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia (4) · Leukemia, Myeloid (4) · Myeloproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, Lymphoid (1)
Imatinib Mesylate (2) · nilotinib (2) · Dasatinib (1) · peginterferon alfa-2b (1)
Australasian Leukaemia and Lymphoma Group (1) · Cell Medica Ltd (1) · University College, London (1) · University of Liverpool (1)
United Kingdom (3) · Australia (1)
Andrew Grigg, MBBS, MD, FRACP, FRCPA (1) · David Yeung, BSc(Med), MBBS(Hons),FRACP (1) · Dr Kavita Raj (1) · Emma Morris, Dr (1) · Richard E Clark, MA MD (1) · Tim Hughes, MBBS, MD, FRACP, FRCPA (1)